Call for an instant quote 0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
01 November 2017 09:18
Taking aspirin reduces risk of liver cancer by almost half
Certain cancers could be kept at bay by taking one aspirin a day, new research suggests.
According to a study of more than 600,000 people, long-term use of aspirin reduces the chance of developing several digestive cancers as well as lung cancer, prostate cancer and leukaemia.
Dramatically-reduced risk
The trial analysed the prevalence of cancer in people who have taken aspirin for six months or longer - an average of 7.7 years - compared with results for those who have not.
The data was obtained over a period of 14 years.
The trial group consists of 206,295 aspirin users and 412,589 who did not take any dose of aspirin.
For the whole group, the results show that 16% developed cancer during the period. However, those taking the medication were almost half (47%) as likely to develop cancer of the liver or oesophagus.
Professor Kelvin Tsoi, lead researcher from the Chinese University of Hong Kong, said: "The findings demonstrate that the long-term use of aspirin can reduce the risk of developing many major cancers.
"What should be noted is the significance of the results for cancers within the digestive tract, where the reductions in cancer incidence were all very substantial, especially for liver and oesophageal cancer."
Wider benefits
Stomach cancer, pancreatic cancer and bowel cancer all had much lower incidence levels, reduced by 38%, 34% and 24% respectively.
The medication is also found to reduce the risk of developing lung cancer (35%), leukaemia (24%) and prostate cancer (14%).
Despite several studies finding links between reduced risk of breast cancer and low-dose aspirin, the study finds no significant impact of aspirin on breast, bladder or kidney cancers.
Cancer survivors and those suffering from cancer can still enjoy holidays and overseas trips if they look to take out comprehensive cancer travel insurance.
19 April 2018
A self-injected smart drug may be the key to easing and preventing pain for migraine sufferers.
[more...]
17 April 2018
Despite its reputation as a party drug, ketamine is licensed as an anaesthetic. A recent US study found use of the drug via a nasal spray led to "significant" improvements in depressive symptoms in the first 24 hours.
Simple brain-training exercises carried out at home have been shown to reduce emotional stress in female breast cancer survivors, it's recently been revealed.
13 April 2018
Drinkers who consume more alcohol than UK guidelines suggest could be cutting years off their lives, according to new research.
12 April 2018
A recent study has revealed that people who sustain brain injuries are at an increased risk of developing dementia later in life.
11 April 2018
Scientists have announced their latest breakthrough in the battle against Alzheimer's disease, after neutralising a high-risk gene in a human brain cell for the first time.
07 April 2018
The Philippines is set to shut its most famous holiday island of Boracay for six months, after the President described it as a "cesspool".
05 April 2018
Taxes on soft drinks, alcohol and tobacco - nicknamed "sin taxes" - could be a powerful step towards combating rising rates of chronic diseases worldwide, research has suggested.
New "one-stop shops" to speed up cancer diagnosis are being trialled across the country for the first time.
30 March 2018
Doctors should tell patients that e-cigarettes are less harmful than smoking but not without risk, according to new national guidance.
29 March 2018
Young people suffering from mental health problems are finding it hard to get the support they need, a survey has revealed.
28 March 2018
Children exposed to epilepsy drugs in the womb may achieve poorer test results at school, a study has suggested.